1. Home
  2. TFSL vs LGND Comparison

TFSL vs LGND Comparison

Compare TFSL & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TFSL
  • LGND
  • Stock Information
  • Founded
  • TFSL 1938
  • LGND 1987
  • Country
  • TFSL United States
  • LGND United States
  • Employees
  • TFSL N/A
  • LGND 68
  • Industry
  • TFSL Savings Institutions
  • LGND Biotechnology: Pharmaceutical Preparations
  • Sector
  • TFSL Finance
  • LGND Health Care
  • Exchange
  • TFSL Nasdaq
  • LGND Nasdaq
  • Market Cap
  • TFSL 3.9B
  • LGND 3.2B
  • IPO Year
  • TFSL 2007
  • LGND 1992
  • Fundamental
  • Price
  • TFSL $13.24
  • LGND N/A
  • Analyst Decision
  • TFSL Hold
  • LGND Strong Buy
  • Analyst Count
  • TFSL 1
  • LGND 8
  • Target Price
  • TFSL $15.00
  • LGND $144.71
  • AVG Volume (30 Days)
  • TFSL 426.3K
  • LGND 139.7K
  • Earning Date
  • TFSL 10-29-2025
  • LGND 08-05-2025
  • Dividend Yield
  • TFSL 8.40%
  • LGND N/A
  • EPS Growth
  • TFSL 3.58
  • LGND N/A
  • EPS
  • TFSL 0.29
  • LGND N/A
  • Revenue
  • TFSL $308,625,000.00
  • LGND $181,488,000.00
  • Revenue This Year
  • TFSL $7.25
  • LGND $18.41
  • Revenue Next Year
  • TFSL $7.66
  • LGND $18.87
  • P/E Ratio
  • TFSL $46.38
  • LGND N/A
  • Revenue Growth
  • TFSL 1.03
  • LGND 53.40
  • 52 Week Low
  • TFSL $11.29
  • LGND $81.74
  • 52 Week High
  • TFSL $15.00
  • LGND $129.90
  • Technical
  • Relative Strength Index (RSI)
  • TFSL 47.57
  • LGND 76.50
  • Support Level
  • TFSL $13.01
  • LGND $179.40
  • Resistance Level
  • TFSL $13.82
  • LGND $186.40
  • Average True Range (ATR)
  • TFSL 0.22
  • LGND 4.74
  • MACD
  • TFSL 0.01
  • LGND 0.29
  • Stochastic Oscillator
  • TFSL 32.10
  • LGND 87.49

About TFSL TFS Financial Corporation

TFS Financial Corp is the holding company for the Third Federal Savings and Loan Association of Cleveland. The company's ownership in the savings and loan association is its primary business activity. The association's principal business consists of originating and servicing residential real estate mortgage loans and attracting retail savings deposits. It does so by offering products with competitive rates and yields. The company also operates Third Capital, a wholly owned subsidiary that serves as a holding company or as an investor in vehicles such as private equity funds. Third Capital has interests in lease transactions of commercial buildings, title agencies providing escrow and settlement services, and reinsurance of private mortgage insurance on residential loans.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: